1. Home
  2. VACHU
  3. VACHU News

Latest VOYAGER ACQUISITION CORP UNIT 1 COM & 1/2 WT EXP (VACHU) News on July 12, 2025

VACHU

GlobeNewswire

a month ago

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
VACHU

GlobeNewswire

2 months ago

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VACHU

MT Newswires

2 months ago

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

VACHU

GlobeNewswire

2 months ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

Veraxa to go public in $1.6bn SPAC deal with Voyager
VACHU

Pharmaceutical Technology

3 months ago

Veraxa to go public in $1.6bn SPAC deal with Voyager

VACHU

MT Newswires

3 months ago

Voyager Acquisition, VERAXA Biotech to Merge, Creating $1.64 Billion Public Cancer Therapy Company

VACHU

GlobeNewswire

3 months ago

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VACHU

GlobeNewswire

10 months ago

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

VACHU

GlobeNewswire

a year ago

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

VACHU

GlobeNewswire

a year ago

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Share on Social Networks: